Category Archives: William Marquardt

Mexico’s New National Anti-Corruption System

With the implementation of the new anticorruption legislation in Mexico in July of 2016, Mexican President Enrique Pena Nieto and the Mexican government have demonstrated their continuing commitment to combat corruption, support transparent governance and improve the ability of organizations to operate free of the systemic corruption that has plagued both the public and private sectors in Mexico for decades. Continue reading Mexico’s New National Anti-Corruption System

Extraterritorial Anti-bribery and Anti-corruption Compliance Requirements – A Third Party Perspective

In Pharmaceutical Compliance Monitor, William Marquardt discusses expectations to comply with extraterritorial anti-bribery and anti-corruption (AB/AC) regulations, and costs associated with these expectations.

CSR Programs and Charitable Donations: FCPA Compliance Challenges

By William Marquardt

Introduction

Companies in the mining and energy sectors often operate in remote locations and find themselves working with indigenous communities who have no official say in the company’s operations, and yet are often dependent on these businesses to provide critical public services. In some jurisdictions these services are part of the concession or a statutory requirement of being allowed to operate in the locality, while others have no formal structure. Continue reading CSR Programs and Charitable Donations: FCPA Compliance Challenges